Component

Anxiety symptom score, instrument specified by study

Anxiety symptom score, instrument specified by study. Species, exposure and limitations are retained in each linked claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Between-group differences reached statistical significance only for tics, not clinician-rated anxiety.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/theanine-research/35215501.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "68809f3eaf29616aa35c472872e3c510e0c8aaf23e8880c43a91f363eaad5ea2", "start_char": 0, "end_char": 1576, "text_sha256": "68809f3eaf29616aa35c472872e3c510e0c8aaf23e8880c43a91f363eaad5ea2"}
    experimental_model
    Randomized open-label comparative trial
    exposure
    Theanine plus vitamin B6 versus psychoeducation
    limitations
    No blinded placebo and no single-ingredient arms. Cannot attribute the effect to either ingredient or prove biochemical synergy.
    nutrient_topic
    L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
    organism
    34 children with Tourette syndrome or chronic tic disorder and anxiety
    plain_language
    Improvements within both groups must not be presented as a proven advantage for anxiety.
    primary_references
    [theanine-p35215501] Use of Nutritional Supplements Based on L-Theanine and Vitamin B6 in Children with Tourette Syndrome, with Anxiety Disorders: A Pilot Study. (2022). https://pubmed.ncbi.nlm.nih.gov/35215501/ DOI: 10.3390/nu14040852
    tissue_or_cell_type
    Clinician-rated tics and anxiety

    L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 887–898

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized open-label comparative trial · source_derived_draft · unverified_draft

    ### theanine-b6-mixture-anxiety-null Between-group differences reached statistical significance only for tics, not clinician-rated anxiety. Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Improvements within both groups must not be presented as a proven advantage for anxiety. organism: 34 children with Tourette syndrome or chronic tic disorder and anxiety tissue_or_cell_type: Clinician-rated tics and anxiety experimental_model: Randomized open-label comparative trial limitations: No blinded placebo and no single-ingredient arms. Cannot attribute the effect to either ingredient or prove biochemical synergy. exposure: Theanine plus vitamin B6 versus psychoeducation evidence_span: {"source_cache": "artifacts/theanine-research/35215501.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "68809f3eaf29616aa35c472872e3c510e0c8aaf23e8880c43a91f363eaad5ea2", "start_char": 0, "end_char": 1576, "text_sha256": "68809f3eaf29616aa35c472872e3c510e0c8aaf23e8880c43a91f363eaad5ea2"} [theanine-p35215501] Use of Nutritional Supplements Based on L-Theanine and Vitamin B6 in Children with Tourette Syndrome, with Anxiety Disorders: A Pilot Study. (2022). https://pubmed.ncbi.nlm.nih.gov/35215501/ DOI: 10.3390/nu14040852
    Complete structured claim and evidence
  2. Adjunctive theanine did not outperform placebo on anxiety severity in the GAD trial (p=0.73).

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/theanine-research/30580081.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "00fa4263444cc6a36149ad1445f431b8930abdb64ca4e30cfce4fc091082a837", "start_char": 0, "end_char": 1664, "text_sha256": "00fa4263444cc6a36149ad1445f431b8930abdb64ca4e30cfce4fc091082a837"}
    experimental_model
    Double-blind placebo-controlled adjunctive trial
    exposure
    450-900 mg/day theanine for eight weeks
    limitations
    Adjunctive setting with stable medication. Overall negative anxiety and insomnia endpoints; a favorable sleep-satisfaction item is narrower.
    nutrient_topic
    L-Theanine research collection; topical membership is not evidence of a direct dietary effect. · L-Theanine
    organism
    46 people with generalized anxiety disorder on stable antidepressants
    plain_language
    Laboratory calming signals do not establish treatment efficacy for an anxiety disorder.
    primary_references
    [theanine-p30580081] L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. (2019). https://pubmed.ncbi.nlm.nih.gov/30580081/ DOI: 10.1016/j.jpsychires.2018.12.014
    tissue_or_cell_type
    Anxiety and insomnia scales

    L-Theanine: metabolism, neural signaling, nutrient connections and human outcomes (2026-09-17) · lines 1108–1119

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Double-blind placebo-controlled adjunctive trial · source_derived_draft · unverified_draft

    ### theanine-gad-anxiety-null Adjunctive theanine did not outperform placebo on anxiety severity in the GAD trial (p=0.73). Condition category: normal nutrient_topic: L-Theanine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Laboratory calming signals do not establish treatment efficacy for an anxiety disorder. organism: 46 people with generalized anxiety disorder on stable antidepressants tissue_or_cell_type: Anxiety and insomnia scales experimental_model: Double-blind placebo-controlled adjunctive trial limitations: Adjunctive setting with stable medication. Overall negative anxiety and insomnia endpoints; a favorable sleep-satisfaction item is narrower. exposure: 450-900 mg/day theanine for eight weeks evidence_span: {"source_cache": "artifacts/theanine-research/30580081.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "00fa4263444cc6a36149ad1445f431b8930abdb64ca4e30cfce4fc091082a837", "start_char": 0, "end_char": 1664, "text_sha256": "00fa4263444cc6a36149ad1445f431b8930abdb64ca4e30cfce4fc091082a837"} [theanine-p30580081] L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. (2019). https://pubmed.ncbi.nlm.nih.gov/30580081/ DOI: 10.1016/j.jpsychires.2018.12.014
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards